Articles

Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model

Hannover Medical School (MHH), Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany;
Haemophilia Centre, National Blood Centre, Kuala Lumpur, Malaysia;
Hospital Universitario La Paz, Autónoma University, Madrid, Spain;
Haemophiliezentrum, Klinik für Innere Medizin, Vivantes Klinikum im Friedrichshain, Berlin, Germany;
Rîga East Clinical University Hospital, Chemotherapy and Hematology Clinic, Rîga, Latvia;
Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan;
Novo Nordisk A/S, Søborg, Denmark;
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Cà Granda Foundation, Maggiore Hospital Policlinic, Milan, Italy
Haematologica Early view Apr 23, 2020 https://doi.org/10.3324/haematol.2019.241554